These findings point to DNase1L3 as the primary target of a subset of antibodies classified as anti-dsDNA, shedding light on the origin and pathogenic heterogeneity of antibodies reactive to dsDNA in SLE. The gene discussed is DNASE1L3; the disease is systemic lupus erythematosus.